Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rupert Bauersachs"'
Autor:
Ulrich Hoffmann, Rupert Bauersachs, Thomas Noppeney, Jens Klotsche, Horst E. Gerlach, Andreas Heinken, Eberhard Rabe, Florian Länger, David Pittrow
Publikováno v:
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 62(2)
Objective Management and outcomes of superficial vein thrombosis (SVT) are highly variable and not well described. Therefore, the INvestigating SIGnificant Health TrendS in the management of SVT (INSIGHTS-SVT) study collected prospective data under r
Autor:
Rupert Bauersachs
Publikováno v:
Thrombosis Research. 140:S160-S164
Venous thromboembolism (VTE) is one of the leading causes of death in cancer patients, which are known to have a 5- to 7-fold increased risk for VTE. The anticoagulant treatment of VTE in cancer patients is less effective with a three-fold increased
Autor:
Rupert Bauersachs
Publikováno v:
Thrombosis Research. 129:107-115
Thromboembolic disorders are a major cause of morbidity and mortality, and the risk of thromboembolism increases with age. Anticoagulants are recommended for indications including the prevention of venous thromboembolism in surgical and medical patie
Autor:
Sebastian Schellong, Sylvia Haas, Claudia Abletshauser, H. Gerlach, Nima Melzer, Rupert Bauersachs, Christian Sieder, Ulrich Tebbe, Peter Bramlage, Hanno Riess
Publikováno v:
Thrombosis and Haemostasis. 105:981-988
SummaryPatients with severe renal insufficiency (sRI) have been suggested to be at an increased risk of bleeding with low-molecular-weight heparins (LMWH). We aimed at assessing the benefits and risks of certoparin in comparison to unfractionated hep
Autor:
Samson Fung, Eberhard Herchenhan, Thorsten Fischer, Michael Spannagl, Joachim W. Dudenhausen, Job Harenberg, Ulrich Geisen, A Faridi, Franz Keller, Rupert Bauersachs, Bettina Kemkes-Matthes, Christian J. Thaler, Helmut Schinzel
Publikováno v:
Thrombosis and Haemostasis. 98:1237-1245
SummaryWomen with a history of venous thromboembolism (VTE), thrombophilia or both may be at increased risk of thrombosis during pregnancy, but the optimal management strategy is not well defined in clinical guidelines because of limited trial data.
Autor:
Rupert Bauersachs, Dialina Brilhante, G T Gerotzafias, Mario Mandalà, Simon Noble, Henri Bounameaux, Ramón Lecumberri, Anna Falanga, H. R. Büller, Michael B. Streiff, C. Baglin, Nissim Haim, Manuel Monreal, Alok A. Khorana, Michel Marty, Dominique Farge, Mohammed H. Qari, Shaker A. Mousa, Philippe Debourdeau, M Beckers, Ingrid Pabinger, Barry M. Brenner, Paolo Prandoni, Ajay K. Kakkar, Martin H. Prins, Konstantinos N. Syrigos
Publikováno v:
Journal of Thrombosis and Haemostasis, 11(1), 71-80. Wiley
Journal of thrombosis and haemostasis, 11(1), 71-80. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, Vol. 11, No 1 (2013) pp. 71-80
Journal of thrombosis and haemostasis, 11(1), 71-80. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, Vol. 11, No 1 (2013) pp. 71-80
Abstract 4357 Background Use of long term indwelling central venous catheter (CVC) is associated with symptomatic (Σ) events in up to 30% of cancer patients (pts), which may lead to pulmonary embolism (PE) and loss of the CVC. Lack of consensus on m